Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Lhermitte's Sign: The Current Status.
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
Biomechanical disorders of foot in multiple sclerosis.
[Vitamin D and multiple sclerosis].
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Can HPV immunisation cause ADEM? Two case reports and literature review.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up.
Pages
« first
‹ previous
…
335
336
337
338
339
340
341
342
343
…
next ›
last »